These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 5715494)

  • 1. Immunological concept of glomerulonephritis; an experimental study.
    Mathur KS
    J Assoc Physicians India; 1968 Oct; 16(10):689-97. PubMed ID: 5715494
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of prednisolone on the course of experimental glomerulonephritis].
    Bykovskaia KN; Vikhert AM; Glezer GA
    Arkh Patol; 1966; 28(4):25-31. PubMed ID: 6000324
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunomorphological profile of experimental glomerulonephritis treated with indocid].
    Vikhert AM; Megrelishvili RI; Ryff IM
    Patol Fiziol Eksp Ter; 1972; 16(5):62-5. PubMed ID: 4596809
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasmapheresis with immunosuppressive therapy vs immunosuppressive therapy alone for rapidly progressive anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis.
    Nakamura T; Matsuda T; Kawagoe Y; Ueda Y; Ebihara I; Koide H
    Nephrol Dial Transplant; 2004 Jul; 19(7):1935-7. PubMed ID: 15199209
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative evaluation of the effectiveness of prednisolone and indotsid in the treatment of experimental autoimmune glomerulonephritis].
    Bykovskaia KN; Megrelishvili RI
    Patol Fiziol Eksp Ter; 1973; 17(2):14-20. PubMed ID: 4710416
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinico-morphologic characteristics of experimental autoimmune glomerulonephritis during the use of prednisolone].
    Bykovskaia KN
    Arkh Patol; 1969; 31(6):32-7. PubMed ID: 5358924
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunosuppressive agents in the treatment of glomerular nephropathies].
    Aparicio M; Cledes J
    Cah Med; 1970 Nov; 11(13):1137-41. PubMed ID: 5502824
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of prednisolone on serum protein fractions in experimental glomerulonephritis].
    Bykovskaia KN
    Biull Eksp Biol Med; 1968 Feb; 65(2):27-30. PubMed ID: 5660892
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy of glomerulonephritis].
    Matthias S; Ritz E; Waldherr R
    Internist (Berl); 1995 Mar; 36(3):218-26. PubMed ID: 7737814
    [No Abstract]   [Full Text] [Related]  

  • 10. [Current trends in the experimental therapy of autoimmune diseases].
    Uteshev BS
    Patol Fiziol Eksp Ter; 1981; (3):71-8. PubMed ID: 6456439
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunological pathogenesis of experimental glomerulonephritis induced by some infectious and toxic agents.
    Fournié GJ; Lulé J; Gayral-Taminh M; Mignon-Conté M; Conté JJ; Belon B; Druet E; Hirsh F; Sapin C; Druet P; Izui S; Lambert PH
    Contrib Microbiol Immunol; 1983; 7():43-51. PubMed ID: 6218966
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunosuppressive therapy of uveitis with corticosteroids and cytostatic drugs].
    Fekete B; Szegedi G; Szabó G; Petrányi G; Bauer N; Gát L
    Orv Hetil; 1972 Aug; 113(34):2036-41. PubMed ID: 5051435
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cyclosporin in treatment of glomerular diseases].
    Krieter DH; Müller GA
    Internist (Berl); 1996 Jan; 37(1):84-8. PubMed ID: 8837833
    [No Abstract]   [Full Text] [Related]  

  • 14. A novel immunosuppressant FTY720 ameliorates proteinuria and alterations of intrarenal adrenomedullin in rats with autoimmune glomerulonephritis.
    Shi Y; Yoshihara F; Nakahama H; Ichimaru N; Yazawa K; Sada M; Goto R; Kawano Y; Moriyama T; Takahara S; Okuyama A; Kangawa K
    Regul Pept; 2005 Apr; 127(1-3):233-8. PubMed ID: 15680492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on experimental hetero-immune nephritis. II. Prevention by immunosuppressive agents and certain anticoagulants].
    Halpern B; Lagrue G; Bariéty J; Morard JC; Fray A
    Pathol Biol; 1967 Apr; 15(7):373-7. PubMed ID: 4864894
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pneumocystis carinii and aspergillus pneumonia in immunosuppression in rapidly progressing glomerulonephritis of the anti-glomerular basement membrane type].
    Späth M; Schollmeyer P
    Med Klin (Munich); 1996 Sep; 91(9):603-6. PubMed ID: 8984320
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunosuppressive therapy of glomerulonephritis--controlled studies].
    Ferrari P; Frey FJ
    Ther Umsch; 1993 Feb; 50(2):119-29. PubMed ID: 8456416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transformation of hepatitis B virus-related membranous glomerulonephritis to crescentic form.
    Taskapan H; Oymak O; Dogukan A; Ozbakir O; Utas C
    Clin Nephrol; 2000 Aug; 54(2):161-3. PubMed ID: 10968695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppression in rapidly progressive Henoch-Schoenlein nephritis.
    Worth DP
    Clin Nephrol; 1996 Feb; 45(2):135-6. PubMed ID: 8846529
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of dyslipoproteinemia by systemic enzyme therapy in experimental glomerulonephritis].
    Mukhin IV
    Patol Fiziol Eksp Ter; 2002; (4):27-8. PubMed ID: 12638428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.